Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A high index level often signals stronger market momentum or potential overbought conditions. Grasp its implications to adjust exposure and risk.
25,713 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Investors are hoarding cash as volatility climbs and policy signals shift risk expectations. The dash cash only just ...
Circle Internet Group’s stock surged about 20% after two U.S. senators announced a bipartisan compromise on stablecoi...
BigBear.AI delivers a stronger Q1 2026, expanding margins and backlog while signaling a ramp in defense contracts. Th...
American Bitcoin reports an $82 million Q1 loss even as it mines a record 817 BTC. Lower BTC prices and rising reserv...
SanDisk, Micron and Western Digital nosedived as investors cash in after a rapid AI memory rally, signaling a pause i...
A new wave of legal challenges has hit kardashian’s skims with lawsuit, shaking up the brand’s polished image. This a...
As AI demand accelerates, Nvidia stands out on a growth-adjusted valuation. Cramer argues the stock is cheaper than p...
PepsiCo beat expectations in Q1 with revenue rising 8.5% and earnings surpassing estimates. International momentum an...
Astera Labs’ stock jumped after management laid out a firm timetable for a new switch and signaled growing opportunit...
Retirees with large traditional 401(K) balances face sizable required minimum distributions starting at age 73. The f...
As IPO risk rises in 2026, Altria’s reliable 6% dividend and decades of payout growth position it as a steadier optio...